News
TipRanks on MSN22h
Pfizer’s Phase 2 Study on PF-06835375: A Potential Breakthrough in ITP Treatment
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 2, open-label, multicenter study titled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback